Elabela, a New Endogenous Ligand of APJ, Functions in Embryos and Adults Organisms.

Liqun Lu,Jiangang Cao,Lanfang Li,Linxi Chen
DOI: https://doi.org/10.1093/abbs/gmx014
IF: 3.7
2017-01-01
Acta Biochimica et Biophysica Sinica
Abstract:Apelin is an endogenous ligand of the APJ receptor (also known as Aplnr) which is a G protein-coupled receptor [1,2]. Elabela (also known as Toddler, Apela), which shares little sequence similarity with Apelin (Fig. 1), has been identified as a new endogenous ligand for APJ receptor [3]. Elabela is encoded by AK092578 gene from a region of the human genome which was previously classified as ‘non-coding’. Elabela is initially translated into a peptide of 54 amino acids including a secretory signal peptide. However, its mature form only contains 32 amino acids. The Elabela/Aplnr axis mainly acts in embryonic development compared with Apelin/APJ system which has abundant biological functions in different physiological and pathological processes [4–8]. During zebrafish embryogenesis, Elabela is proved to be indispensable for the proper differentiation of endodermal precursors which guide the overlying cardiac progenitors to the heart-forming region to initiate cardiogenesis [3]. Therefore, loss of Elabela causes severe cardiac dysplasia ranging from a rudimentary heart to no heart, and has little to no blood circulation. Elabela expresses concomitantly with Aplnr before the onset of gastrulation, and loss of Elabela phenocopies the loss of Aplnr during early heart development. However, Apelin is not expressed until midgastrulation and Apelin zebrafish morphants are not presented with overt congenital cardiac anomalies. Thus, the Elabela/Aplnr axis appears to be exclusive for endoderm differentiation and subsequent cardiogenesis [3] (Fig. 2). A recent study elaborates that DNA-bound active fraction (F2) of the zebrafish pluripotency factor Pou5f3 (homologous to mammalian Oct4) is essential for early zebrafish development [9]. At the blastula stage, the Pou5f3 interacts with Nanog to pattern mesendoderm differentiation. Later, during gastrulation, Sox32 restricts Pou5f3– Nanog complexes to the ventrolateral mesendoderm through binding either to Pou5f3 or Nanog in the dorsal endoderm. The Elabela/ Aplnr pathway inhibits Sox32 levels to up-regulate the proportion of Pou5f3–Nanog complexes in ventrolateral endodermal cells, which may activate the BMP (bone morphogenetic protein) signaling in the mesendoderm lineage [9]. As for the BMP signaling, it plays fundamental roles in both embryonic skeletal development and postnatal bone homeostasis [10,11]. Owing to this phenomenon, the Elabela/Aplnr pathway contributes to skeletal development, bone formation, and bone homeostasis (Fig. 2). Elabela is also able to induce vasculogenesis in zebrafish embryos [12]. The migration of endothelial precursors and angioblasts to the position of the future vessels acts as a key step in the formation of the embryonic vasculature [13]. To form the first axial vessels, the angioblasts need to migrate toward the midline and coalesce underneath the notochord. Helker et al. [12] showed that Elabela/Aplnr signaling represents a ligand-receptor pair in guiding the angioblasts to the midline, and the Elabela/Aplnr signaling, therefore playing an important role during vasculogenesis in zebrafish embryos (Fig. 2). Elabela is also reported to regulate apoptosis in embryonic stem cells. Li et al. [14] investigate that Elabela is suppressed by p53 and its protein-coding ability is not required for its pro-apoptotic function in mouse embryonic stem cells (mESCs). They further demonstrated that Elabela acts as a regulatory RNA and binds to heterogeneous nuclear ribonucleoprotein L (hnRNPL), an inhibitory regulator of p53, to decrease the interaction between hnRNPL and p53. As a result, Elabela enhances the expression of p53 in mESCs. Therefore, p53, Elabela, and hnRNPL form a tri-element negative feedback loop in p53-mediated DNA damage-induced apoptosis. Ho et al. [15] showed that Elabela, which is abundantly produced by human embryonic stem cell (hESCs), has a dual function in maintaining the self-renewing state and poising hESCs toward the mesendoderm lineage. On one hand, Elabela activates the autocrine/ paracrine PI3K/AKT signaling to promote cell-cycle progression and optimal protein translation, and prevents cellular stress-induced apoptosis to support self-renewal of hESCs. It is noteworthy that Elabela only promotes the growth of hESCs, not other differentiated cell types such as primary human fibroblasts. On the other hand, Elabela is responsible for priming hESCs to endodermal differentiation via potentiating the TGF-β pathway. In these two processes, Elabela may function through binding to an alternative unknown
What problem does this paper attempt to address?